Works matching IS 0344-5704 AND VI 92 AND IP 1 AND DT 2023

Results: 8

A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 57, doi. 10.1007/s00280-023-04548-1
By:
- König, Philipp;
- Zhulenko, Roman;
- Suparman, Eloy;
- Hoffmeister, Henrik;
- Bückreiß, Nico;
- Ott, Ingo;
- Bendas, Gerd
Publication type:
Article
Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02).
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 29, doi. 10.1007/s00280-023-04547-2
By:
- Hasegawa, Tsukasa;
- Ariyasu, Ryo;
- Tanaka, Hisashi;
- Saito, Ryota;
- Kawashima, Yosuke;
- Horiike, Atsushi;
- Sakatani, Toshio;
- Tozuka, Takehiro;
- Shiihara, Jun;
- Saiki, Masafumi;
- Tambo, Yuichi;
- Sonoda, Tomoaki;
- Miyazaki, Akito;
- Uematsu, Shinya;
- Tsuchiya-Kawano, Yuko;
- Yanagitani, Noriko;
- Nishino, Makoto
Publication type:
Article
Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 51, doi. 10.1007/s00280-023-04546-3
By:
- Singh, Minu;
- Bhaskar, Divya;
- Bhatia, Prateek;
- Thakur, Rozy;
- Sharma, Pankaj;
- Bansal, Deepak;
- Jain, Richa;
- Trehan, Amita
Publication type:
Article
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 15, doi. 10.1007/s00280-023-04544-5
By:
- Rasco, Drew W.;
- Medina, Theresa;
- Corrie, Pippa;
- Pavlick, Anna C.;
- Middleton, Mark R.;
- Lorigan, Paul;
- Hebert, Chris;
- Plummer, Ruth;
- Larkin, James;
- Agarwala, Sanjiv S.;
- Daud, Adil I.;
- Qiu, Jiaheng;
- Bozon, Viviana;
- Kneissl, Michelle;
- Barry, Elly;
- Olszanski, Anthony J.
Publication type:
Article
Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 7, doi. 10.1007/s00280-023-04542-7
By:
- Oura, Mitsuaki;
- Oguro, Fumiya;
- Agatsuma, Nobukazu;
- Imamaki, Hirotaka;
- Nishikawa, Yoshitaka
Publication type:
Article
Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 1, doi. 10.1007/s00280-023-04540-9
By:
- Purvis, Katelyn N.;
- Swanson, Hope D.;
- Niloy, Kumar Kulldeep;
- Zhou, Yiwang;
- Panetta, John C.;
- Crews, Kristine R.;
- Flerlage, Jamie E.
Publication type:
Article
ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 39, doi. 10.1007/s00280-023-04539-2
By:
- Kagan, Amanda B.;
- Moses, Blake S.;
- Lapidus, Rena;
- Mott, Bryan T.;
- Rai, Ganesha;
- Anders, Nicole M.;
- Hoag, Stephen W.;
- Rudek, Michelle A.;
- Civin, Curt I.
Publication type:
Article
Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 71, doi. 10.1007/s00280-023-04533-8
By:
- Hong, Lan;
- Wang, Xiuzhen;
- Zheng, Lang;
- Wang, Shengtan;
- Zhu, Genhai
Publication type:
Article